drugset / Trial / NCT00052377
Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides
NaSingle-groupOpen-labelTreatment
Summary
Phase I/II trial to study the effectiveness of combining interleukin-12 with interleukin-2 in treating patients who have mycosis fungoides. Biological therapies, such as interleukin-12 and interleukin-2, use different ways to stimulate the immune system and stop cancer cells from growing. Combining more than one biological therapy may kill more tumor cells
Timeline
- Start
- 2002-09
- Primary completion
- 2005-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | aldesleukin | Protein / enzyme biologic | — | Subcutaneous |
| Subject | interleukin-12 | Protein / enzyme biologic | — | Subcutaneous |